{"id":56131,"date":"2024-03-20T11:04:56","date_gmt":"2024-03-20T11:04:56","guid":{"rendered":"https:\/\/biomedpharmajournal.org\/?p=56131"},"modified":"2024-04-01T19:30:47","modified_gmt":"2024-04-01T19:30:47","slug":"therapeutic-potential-of-coriander-coriandrum-sativum-seeds-extract-treatment-on-hematological-and-biochemical-parameters-in-healthy-and-trichinella-spiralis-infected-mice","status":"publish","type":"post","link":"https:\/\/biomedpharmajournal.org\/staging\/vol17no1\/therapeutic-potential-of-coriander-coriandrum-sativum-seeds-extract-treatment-on-hematological-and-biochemical-parameters-in-healthy-and-trichinella-spiralis-infected-mice\/","title":{"rendered":"Therapeutic Potential of Coriander (Coriandrum sativum) Seeds Extract Treatment on Hematological and Biochemical Parameters in Healthy and Trichinella spiralis Infected Mice"},"content":{"rendered":"\n

Introduction<\/strong><\/p>\n\n\n\n

Trichinellosis is a parasitic zoonosis that is spread through\ningesting raw or undercooked meat that has been contaminated with Trichinella\nspiralis larvae.1-3<\/sup>  It has\nthree clinical phases: intestinal, migratory, and muscular. Pork and its products\nare the main sources of infection.4-6<\/sup>  According to Saad et al.7<\/sup> and Abou\nRayia et al.8<\/sup>, T. spiralis has the unusual capacity to change the\ninfected muscle cell into a new kind of cell known as a nurse cell in the host\nbody. Trichinellasag spiralis has been frequently used as an experimental model\nto determine the effects of numerous anthelmintic agents because it can develop\ninto adult, migratory, and encysted stages in the same host and infects a wide\nrange of mammalian hosts.9<\/sup> According to Gottstein et al.10<\/sup>,\nmebendazole is the standard therapy and the main anthelmintic medication for\nthe treatment of trichinellosis in the majority of cautery and in KSA. However,\naccording to Caner et al.11<\/sup>, they exhibit modest efficacy against\nencapsulated larvae, a high level of resistance, and restricted\nbioavailability. Medical plants create a wide range of chemical\ncomponents that can treat a wide range of illnesses.12,13<\/sup> The seeds\nof the fragrant, carminative, stomachic, and antispasmodic annual plant Coriandrum sativum <\/em>L.\n(coriander, family Apiaceae) are used in medicine to treat abdominal symptoms\nsuch dyspepsia, and gastralgia. To avoid stomach aches, they are also a\ncomponent in laxative remedies. Thanks to the\nidentification of certain polyphenolic and antioxidant components present in\nthe coriander plant, it has been shown to play a substantial role in the\naetiology of a number of disorders.14<\/sup> Coriander is used in folk\nmedicine to treat rheumatism and joint discomfort as well as intestinal\nparasites.15<\/sup> Because of this, the current investigation looked at\nhow therapy with coriander affected hematological and biochemical variables in mice with Trichinella spiralis<\/em>\ninfection as well as healthy mice.<\/p>\n\n\n\n

Materials and Methods<\/strong><\/p>\n\n\n\n

Making coriander seed extracts (CSE)<\/strong><\/p>\n\n\n\n

In accordance with Moustafa et al.16<\/sup>, coriander seeds\n(CS) were powdered, soaked in boiling water for 24 hours, extracted, and then\nstored at -30\u00b0C in the dark until use.<\/p>\n\n\n\n

Animals and Ethical Considerations<\/strong><\/p>\n\n\n\n

A total of 40 male Swiss male\nalbino mice were employed in this\ninvestigation, and they appeared to be in good health and free of parasites. 10\nmice each were divided into 4 equal groups (Gps) of mice. The mice were bought in Giza, Egypt, from\nNRC. Prior to the trial, mice were kept at our faculty’s animal home for a\nweek. They were kept in controlled lighting conditions with a conventional\nmouse feed and access to water at all times. Experimental design and animal groups<\/strong><\/p>\n\n\n\n

Gp1: Control group (Control), in which normal healthy non-infected mice.  <\/p>\n\n\n\n

Gp2: Coriandrum Gp (CSE) where mice treated orally (50 mg\/kg body weight) daily for one week.<\/p>\n\n\n\n

Gp3: Infected group (5WPI), in which mice were challenged with 300 larvae of trichinella spiralis<\/em> for 5 weeks.<\/p>\n\n\n\n

Gp4: Post treated group (5WPI+CSE), in which mice were challenged with 300 larvae of trichinella spiralis<\/em> muscle larvae for 5 weeks then treated with CSE for 1 week post infection.<\/p>\n\n\n\n

Sample collection <\/strong><\/p>\n\n\n\n

At the end of the experiment, overnight\nfasted rats will be anaesthetized with diethyl ether, dissection and blood will\nbe collected in EDTA tubes for CBC determination and half of tubes were\ncentrifuged at 3000 g for 20 min. plasma will be carefully separated, each of\nsamples will label and kept at – 20 0<\/sup>C until parasitological, and\nbiochemical analysis.<\/p>\n\n\n\n

Isolation and infection of Trichinella\nspiralis muscle larvae <\/strong><\/p>\n\n\n\n

T. spiralis<\/em> muscle larvae were obtained from laboratory bred infected\nrats in parasitology unit, Faculty of Medicine, Tanta University. Larval\npreparation and extraction of inoculums were made after Dunn and Wright.17<\/sup>\nFive weeks after infection (5WPI),1% pepsin and 1% concentrated HCL are added\nto warm tap water to create an artificial gastric juice that is used to digest\nthe muscles of infected mice. The mixture was incubated for 2 hours at\n37\u00b0C while being continuously stirred by an electric stirrer. The digest\nwas then filtered by sieve (50mesh\/cm2), then by sieve (200mesh\/cm2).18<\/sup>\nAfter being collected, the larvae were rinsed in tap water two to three times\nbefore being suspended in a conical flask for 30 minutes to allow for\nsedimentation. Sediment larvae were counted microscopically while using a\nhemocytometer, and the supernatant fluid was discarded. Dead larvae were\nnon-mobile and comma-shaped, whereas living larvae were coiled and motile.\nThe Concentration of counted larvae in the fluid was adjusted to the\nappropriate dose for each rat, which is 0.25 ml of fluid containing 300 living\nlarvae. Mice were starved for 12 hours before infection, then provided with\n0.25ml of the infection orally by using a tuberculin syringe fitted with blunt,\ncurved, 18-gauge needle to introduce infective larvae into mouse stomach. <\/p>\n\n\n\n

Hematological\nstudies<\/strong><\/p>\n\n\n\n

Complete blood picture (CBC)\nmeasurements were made in 2007 using a Nihon Kohden Corporation, Tokyo, Japan,\nautomated hematology cell counter (serial number 11649, model Celltac,\nMEK-6410K). The following blood parameters were measured: mean corpuscular\nvolume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin\nconcentration (MCHC), white blood cell count (WBC) and its differential, red\nblood cell (RBC) count, hemoglobin (Hb) level, hematocrit (HCT), and platelet\ncount (PLT).<\/p>\n\n\n\n

Liver and\nKidney functions estimation<\/strong><\/p>\n\n\n\n

Reitman and Frankel’s 19\n<\/sup>approach was used to measure the activities of ALT and AST in serum,\nwhereas Belfield and Goldberge’s 20<\/sup>   method was used to measure the activity of ALP.\nTotal protein concentration was calculated using Simonian’s method 21<\/sup>,\nwhereas albumin concentration was calculated using Abd Eldaim et al.’s approach\n22<\/sup>. According to Patton and Crouch (1977) urea and creatinine were\nestimated.<\/p>\n\n\n\n

Statistical Analysis<\/strong><\/p>\n\n\n\n

Results were analysed\nusing an adapted SPSS programme. Data are presented as mean \u00b1 standard error of\nmean (SEM). A one-way ANOVA followed by Dunnett\u2019s test was used to analyse the\ndifferences between groups. Unpaired T-test was used to assess the level of\nstatistical significance between the groups, with the threshold set at\np<0.01.<\/p>\n\n\n\n

Results<\/strong><\/p>\n\n\n\n

Clinical signs<\/strong><\/p>\n\n\n\n

Only six out of twenty rats given an injection of T. spiralis<\/em> larvae exhibited the peri-orbital edema, dyspnea, and respiratory issues that are indicative of trichinellosis during the infection period (Fig. 1). Figure 1 Photomicrograph revealed skeletal muscle fibers with marked fibrosis and marked inflammatory cellular infiltration with mas\u00adsive numbers of T. spiralis <\/em>encysted encapsulated larvae. Table 1 revealed the mean number of Trichinella spiralis<\/em> encysted larvae in mice diaphragms after 5 weeks of infections and in one week treatments with CSR after 5 week post infection with Trichinella spiralis<\/em> (5WPI+CSE). 5WPI+CSE induced reduction in the number of Trichinella spiralis<\/em> encysted larvae.<\/p>\n\n\n\n\n\n
\"\"<\/td>\n\n

Figure 1: <\/strong>Photomicrograph of skeletal muscle sections <\/strong>stained with Haematoxylin & Eosin revealed m<\/strong>uscle fibers with <\/strong>marked fibrosis and marked inflammatory cellular infiltration<\/strong> (arrow heads) with mas\u00adsive numbers of T. spiralis <\/em>encysted <\/strong>encapsulated <\/strong>larvae (arrows).<\/strong><\/p>\n

<\/p>\n

Click here to view Figure<\/a><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n

Table 1: Changes in complete blood picture (CBC) parameters in different groups.<\/strong><\/p>\n\n\n\n\n\n\n\n\n
\n

\n<\/p><\/td>\n

\n

5WPI<\/strong><\/p>\n<\/td>\n

\n

5WPI+CSE<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Number mean <\/strong>\u00b1 SE<\/strong><\/p>\n<\/td>\n

\n

1849.3 \u00b1 380.0<\/p>\n<\/td>\n

\n

746.5 \u00b1 129.1<\/p>\n<\/td>\n<\/tr>\n

\n

Range<\/strong><\/p>\n<\/td>\n

\n

2250-1604<\/p>\n<\/td>\n

\n

962-570<\/p>\n<\/td>\n<\/tr>\n

\n

% of reduction<\/strong><\/p>\n<\/td>\n

\n

0 \u00b1 0<\/p>\n<\/td>\n

\n

59.7%<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n

Table (2)\nrevealed a significant decrease in the levels of Hb, RBCs count, HCT, MCV, MCH, PLT\nand lymphocytes percentage in 5 week post infection with Trichinella spiralis<\/em> (5WPI). On the other hand; 5WPI induced significant increase in\nWBCs counts, neutrophil,\nmonocyte and  eosinophil percentage when compared to control and CSE. Treatments of 5WPI with CSE for\n1 week (5WPI+CSE) induced significant increase in the levels of Hb, RBCs count, HCT, MCV, MCH, PLT,\nlymphocytes percentage and significant decrease in WBCs counts, neutrophil, monocyte and  eosinophil percentage when compared to 5WPI group (Table 2).<\/p>\n\n\n\n

Table 3 showed a significant elevation in the activities of ALT, ALP, AST, urea, creatinine and a significant depletion in the levels of albumin, total proteins in 5WPI group as compared to control and CSE groups. Meanwhile, treatments of 5WPI with CSE (5WPI+CSE) revealed a significant depletion in the activities of ALT, ALP, AST, urea, creatinine and a significant elevation in the levels of albumin, total proteins as compared to 5WPI group.<\/p>\n\n\n\n

Discussion<\/strong><\/p>\n\n\n\n

It is still crucial to find novel ways to diagnose and manage\nzoonotic infections in developing nations, especially considering the\npossibility of human-animal contact there growing over time. With the ability\nto infect a wide range of mammals, including humans, T. spiralis<\/em> is\nstill regarded as one of the most dangerous and widely spread foodborne\nzoonotic nematodes.8<\/sup> Drugs administered in trichinellosis patients\ninclude anthelmintics and steroids. Anthelmintics are the principal drugs for\nthe treatment of Trichinellosis. A strong effort is currently being directed\ntoward the development of an effective treatment against Trichinellosis. <\/p>\n\n\n\n

Table 2: Changes in complete blood picture (CBC) parameters in different groups.<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

 <\/p>\n<\/td>\n

\n

Control<\/strong><\/p>\n<\/td>\n

\n

CSE<\/strong><\/p>\n<\/td>\n

\n

5WPI<\/strong><\/p>\n<\/td>\n

\n

5WPI+CSE<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

Hb (g\/dl)<\/strong><\/p>\n<\/td>\n

\n

10.8#<\/sup><\/strong> \u00b1 0.69<\/p>\n<\/td>\n

\n

11.1#<\/sup><\/strong> \u00b1 0.88<\/p>\n<\/td>\n

\n

9.6* \u00b1 0.40<\/p>\n<\/td>\n

\n

10.4#<\/sup><\/strong> \u00b1 0. 70<\/p>\n<\/td>\n<\/tr>\n

\n

RBC (million\/ul)<\/strong><\/p>\n<\/td>\n

\n

4.23#<\/sup><\/strong> \u00b10.17<\/p>\n<\/td>\n

\n

4.41#<\/sup><\/strong> \u00b10.35<\/p>\n<\/td>\n

\n

4.09*\u00b10.25<\/p>\n<\/td>\n

\n

4.16*#<\/sup><\/strong> \u00b1 0.39<\/p>\n<\/td>\n<\/tr>\n

\n

Hct %<\/strong><\/p>\n<\/td>\n

\n

35.6#<\/sup><\/strong> \u00b12.20<\/p>\n<\/td>\n

\n

36.3#<\/sup><\/strong> \u00b12.07<\/p>\n<\/td>\n

\n

31.7* \u00b1 1.98<\/p>\n<\/td>\n

\n

34.3#<\/sup><\/strong> \u00b1 1.33<\/p>\n<\/td>\n<\/tr>\n

\n

MCV(fl)<\/strong><\/p>\n<\/td>\n

\n

84.2\u00b16.04<\/p>\n<\/td>\n

\n

83.0\u00b15.39<\/p>\n<\/td>\n

\n

77.5* \u00b1 4.55<\/p>\n<\/td>\n

\n

82.5#<\/sup><\/strong> \u00b1 4. 05<\/p>\n<\/td>\n<\/tr>\n

\n

MCH (pg)<\/strong><\/p>\n<\/td>\n

\n

25.5#<\/sup><\/strong> \u00b1 1.60<\/p>\n<\/td>\n

\n

25.2#<\/sup><\/strong> \u00b1 0.91<\/p>\n<\/td>\n

\n

23.5* \u00b1 1.14<\/p>\n<\/td>\n

\n

4.74*#<\/sup><\/strong> \u00b1 0. 33<\/p>\n<\/td>\n<\/tr>\n

\n

MCHC (g\/dl)<\/strong><\/p>\n<\/td>\n

\n

30.3 \u00b12.19<\/p>\n<\/td>\n

\n

30.3 \u00b11.75<\/p>\n<\/td>\n

\n

30.3\u00b12.05<\/p>\n<\/td>\n

\n

30.3 \u00b1 2.17<\/p>\n<\/td>\n<\/tr>\n

\n

Platelets (103 <\/sup>\/ul)<\/strong><\/p>\n<\/td>\n

\n

735.0#<\/sup><\/strong> \u00b111.88<\/p>\n<\/td>\n

\n

741.0#<\/sup><\/strong> \u00b111.50<\/p>\n<\/td>\n

\n

559.0* \u00b1 9.35<\/p>\n<\/td>\n

\n

618.0*#<\/sup><\/strong> \u00b1 10.23<\/p>\n<\/td>\n<\/tr>\n

\n

WBC (103 <\/sup>\/ul)<\/strong><\/p>\n<\/td>\n

\n

6.2#<\/sup><\/strong> \u00b1 0.44<\/p>\n<\/td>\n

\n

6.1#<\/sup><\/strong> \u00b1 0.42<\/p>\n<\/td>\n

\n

11.45* \u00b1 1.16<\/p>\n<\/td>\n

\n

8.9*#<\/sup><\/strong> \u00b1 0. 60<\/p>\n<\/td>\n<\/tr>\n

\n

Neutrophil %<\/strong><\/p>\n<\/td>\n

\n

29.0#<\/sup><\/strong> \u00b11.06<\/p>\n<\/td>\n

\n

30.6#<\/sup><\/strong> \u00b11.82<\/p>\n<\/td>\n

\n

36.0*\u00b11.75<\/p>\n<\/td>\n

\n

33.9*#<\/sup><\/strong> \u00b1 2.08<\/p>\n<\/td>\n<\/tr>\n

\n

Lymphocyte %<\/strong><\/p>\n<\/td>\n

\n

61.2#<\/sup><\/strong> \u00b13.81<\/p>\n<\/td>\n

\n

62.0#<\/sup><\/strong> \u00b13.25<\/p>\n<\/td>\n

\n

50.0* \u00b1 2.92<\/p>\n<\/td>\n

\n

56.2*#<\/sup><\/strong> \u00b1 3.70<\/p>\n<\/td>\n<\/tr>\n

\n

Monocyte %<\/strong><\/p>\n<\/td>\n

\n

6.3*#<\/sup><\/strong> \u00b10.51<\/p>\n<\/td>\n

\n

5.0#<\/sup><\/strong> \u00b10.40<\/p>\n<\/td>\n

\n

8.0* \u00b1 0.55<\/p>\n<\/td>\n

\n

5.2#<\/sup><\/strong> \u00b1 0. 64<\/p>\n<\/td>\n<\/tr>\n

\n

Eosinophil %<\/strong><\/p>\n<\/td>\n

\n

3.5#<\/sup><\/strong> \u00b1 0.28<\/p>\n<\/td>\n

\n

2.4#<\/sup><\/strong> \u00b1 0.17<\/p>\n<\/td>\n

\n

6.0* \u00b1 0.49<\/p>\n<\/td>\n

\n

4.7*#<\/sup><\/strong> \u00b1 0. 29<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

*: Significant difference from the control group at p < 0.05, #<\/sup>: Significant difference from the Trichinella spiralis<\/em> infection(5WPI) group at p < 0.05.<\/p>\n\n\n

Table 3: Changes in the liver and kidney functions in different groups.<\/strong><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

 <\/p>\n<\/td>\n

\n

Control<\/strong><\/p>\n<\/td>\n

\n

CSE<\/strong><\/p>\n<\/td>\n

\n

5WPI<\/strong><\/p>\n<\/td>\n

\n

5WPI+CSE<\/strong><\/p>\n<\/td>\n<\/tr>\n

\n

ALT (U\/I)<\/strong><\/p>\n<\/td>\n

\n

37.9#<\/sup><\/strong> \u00b1 1.65<\/p>\n<\/td>\n

\n

35.5#<\/sup><\/strong>\u00b1 1.70<\/p>\n<\/td>\n

\n

83.0* \u00b1 3.25<\/p>\n<\/td>\n

\n

61.3*#<\/sup><\/strong>\u00b1 3.08<\/p>\n<\/td>\n<\/tr>\n

\n

AST (U\/I)<\/strong><\/p>\n<\/td>\n

\n

81.0#<\/sup><\/strong> \u00b1 3.45<\/p>\n<\/td>\n

\n

72.5#<\/sup><\/strong> \u00b1 4.15<\/p>\n<\/td>\n

\n

109.2* \u00b1 7.52<\/p>\n<\/td>\n

\n

96.0*#<\/sup><\/strong> \u00b1 5.14<\/p>\n<\/td>\n<\/tr>\n

\n

ALP (U\/I)<\/strong><\/p>\n<\/td>\n

\n

102.5#<\/sup><\/strong> \u00b1 6.75<\/p>\n<\/td>\n

\n

93.9#<\/sup><\/strong> \u00b1 5.42<\/p>\n<\/td>\n

\n

125.0* \u00b1 8.76<\/p>\n<\/td>\n

\n

116.2* \u00b1 8.51<\/p>\n<\/td>\n<\/tr>\n

\n

Albumin (mg\/dl)<\/strong><\/p>\n<\/td>\n

\n

4.11#<\/sup><\/strong> \u00b1 0.39<\/p>\n<\/td>\n

\n

4.25#<\/sup><\/strong> \u00b1 0.28<\/p>\n<\/td>\n

\n

3.05* \u00b1 0.31<\/p>\n<\/td>\n

\n

4.74*#<\/sup><\/strong> \u00b1 0. 33<\/p>\n<\/td>\n<\/tr>\n

\n

Total protein <\/strong>(mg\/dl)<\/strong><\/p>\n<\/td>\n

\n

5.86#<\/sup><\/strong> \u00b10.42<\/p>\n<\/td>\n

\n

6.11#<\/sup><\/strong> \u00b10.48<\/p>\n<\/td>\n

\n

3.85*\u00b10.29<\/p>\n<\/td>\n

\n

4.54*#<\/sup><\/strong> \u00b1 0.35<\/p>\n<\/td>\n<\/tr>\n

\n

Creatinine (mg\/dl)<\/strong><\/p>\n<\/td>\n

\n

0.65#<\/sup><\/strong> \u00b10.05<\/p>\n<\/td>\n

\n

0.63#<\/sup><\/strong> \u00b10.08<\/p>\n<\/td>\n

\n

0.95* \u00b1 0.08<\/p>\n<\/td>\n

\n

0.70#<\/sup><\/strong> \u00b1 0.05<\/p>\n<\/td>\n<\/tr>\n

\n

Urea (mg\/dl)<\/strong><\/p>\n<\/td>\n

\n

31.9\u00b12.14<\/p>\n<\/td>\n

\n

28.5\u00b12.65<\/p>\n<\/td>\n

\n

43.5* \u00b1 2.31<\/p>\n<\/td>\n

\n

33.0#<\/sup><\/strong> \u00b1 2. 83<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

*: Significant difference from the control group at p < 0.05, #<\/sup>: Significant difference from the Trichinella spiralis<\/em> infection(5WPI) group at p < 0.05.<\/p>\n\n\n

These treatments have not proven their ability to fight and eliminate Trichinella spiralis <\/em>effectively, so it was necessary to find new drug more effective for T. spiralis <\/em>treatments. Consequently, the current research sought tothe impact of coriander treatment as new treatments on hematological and biochemical parameters in healthy and Trichinella spiralis<\/em> infected mice. <\/p>\n\n\n\n

30% of infected rats with Trichinella spiralis<\/em> showed clinical signs as peri-orbital edema, dyspnea, and respiratory problems\nwithout changes in body temperature during the infection time. Current results\nagree with Ribicich et al. 24<\/sup> who reported that; only two of nine\npigs inoculated with T. spiralis<\/em> larvae showed clinical signs consistent\nwith trichinellosis. Treatments of\n5WPI with CSE for one week showed a 59.6% reduction in number of larvae\nencysted in diaphragms of infected rats. Our findings are consistent with those\nof Abu El Ezz 25<\/sup> and Soliman et al. 26<\/sup>, who found that\nuntreated rats’ diaphragms had a large number of migratory larvae. Both in\nvitro and in vivo studies have shown that biological components found in CSE,\nincluding as polyphenols, tocopherols, and sterols, have potent anti-parasitic\nactivities. 27,28<\/sup> <\/p>\n\n\n\n

Current results\nshowed that; infected\nrats with Trichinella spiralis<\/em> for\n5WPI induced significant decrease in the levels of Hb, RBC count, HCT, MCV, MCH,\nplatelet count (PLT), lymphocytes percent\nand significant increase in WBCs, neutrophil, monocytes, eosinophil percent and\nthe treatments with CSE improved these parameters. Low MCV\nand MCH means your hemoglobin production is less than normal. As a result, the\nnumber of healthy red blood cells also decreases, leading to anemia.  Mean corpuscular volume and\nmean corpuscular hemoglobin are lower than the healthy range, it may indicate\niron-deficiency anemia and microcytosis. Our findings are consistent with those of Ribicich et al. 24<\/sup>,\nwho discovered that pigs implanted with 500 and 5000 larvae between 1 and 6\nweeks after contracting Trichinella spiralis had lower haemoglobin values and\nhigher white blood cell counts. Our results in the line of Sugane et al. 29<\/sup>\nwho reported that T.\ncanis<\/em> infection was induced elevation in WBCs count and eosinophil\npercent. Eosinophilia and infection severity are correlated. Additionally with\nOto et al. 30<\/sup>, who investigated T. canis<\/em>-caused eosinophilic\nmeningo-encephalo-myelitis. On the first day after infection, a rise in\neosinophils and basophils directly denotes the initiation of a primary-allergic\nreaction in the body. T. spiralis<\/em> create a significant allergic reaction\nwhen they enter the body. 31<\/sup> Allergy symptoms are brought on by the\nhistamines that basophil cells produce. It is feasible to check the blood’s\nneutrophil count in addition to the clinical signs of invasion during T.\nspiralis infection and its early identification. This study shows that during\nthe 5-week experiment, this marker is raised when compared to the control.\nAccording to Ovington and Behm 32<\/sup>, the presence of neutrophils and\nmonocytes in the infiltrates of enclosing nurse cells indicates that an\nisolated rise in neutrophils is a sign of capsule development.<\/p>\n\n\n\n

Our findings showed that, in comparison to control (healthy mice\nwho were not infected with T. spiralis<\/em>), T. spiralis<\/em> infection (5WPI) caused a substantial increase\nin blood AST, ALT, ALP, urea, and creatinine levels and a significant decrease\nin serum total proteins and albumin. According to Gamble et al. 33<\/sup>\nand Nada et al. 34<\/sup>, who confirmed that elevated AST and ALT is\npointing to hepatic damage, while increased urea and creatinine is indicative\nof a kidney disease, these changes may be attributed to liver and kidney\ndamages induced during larval migration. According to Saggu et al. 35<\/sup>,\nALP is an enzyme that serves as a marker for the plasma membrane. Any of the\ntwo anomalies (an increase in normal levels or a decrease in normal levels) may\nresult from damage to the biological membrane. This shows potential injury to\nthe plasma membrane of the experimental rat tissues, and this conclusion is\nconsistent with that of Adeyemi et al.36<\/sup>. Current study agreed with\nMikhail 37<\/sup> who find that T. spiralis <\/em>infection induced in ALT\nand AST. Additionally, this investigation supported the findings of Basyoni and\nEl-Sabah 38<\/sup> and Soliman et al. 26<\/sup> who reported that;\nAfter T. spiralis infection, levels of total proteins and albumin decreased.\nThe decrease in total proteins and albumin levels may be caused by the\nmigratory larvae damaging the liver parenchyma or by the metabolic byproducts\nof the parasites harming the liver.<\/p>\n\n\n\n

Conclusion<\/strong><\/p>\n\n\n\n

Trichinella spiralis <\/em>experimentallyinfection (5WPI) induced significant changes in hematological parameters, liver and kidney functions and the treatments of 5WPI with CSE (5WPI+CSE) induced a significant reduction in the number of Trichinella spiralis<\/em> encysted larvae and improvements in all hematological parameters, liver and kidney functions. <\/p>\n\n\n\n

Acknowledgement<\/strong><\/p>\n\n\n\n

None<\/p>\n\n\n\n

Conflict of Interest<\/strong><\/p>\n\n\n\n

The authors declare no competing interests. <\/p>\n\n\n\n

Funding Sources<\/strong><\/p>\n\n\n\n

There is no funding Sources<\/p>\n\n\n\n

Data availability<\/strong><\/p>\n\n\n\n

All the data and material were available. The data of this article are included within the article and its additional files.<\/p>\n\n\n\n

References<\/strong><\/p>\n\n\n\n

  1. Pozio, E., Rinaldi, L., Marucci, G., Musella, V., Galati, F., Cringoli, G., Boireau, P. and La Rosa, G. Hosts and habitats of Trichinella spiralis and Trichinella britovi in Europe. International journal for parasitology<\/em>, 2009;39(1): 71-79.
    CrossRef<\/a><\/li>
  2. Pozio, E., and  Marucci, G. Trichinella-infected pork products: a dangerous gift. Trends in parasitology. 2003; 19(8): 338.
     CrossRef <\/a><\/li>
  3. Ibrahim, S., Sarhan, M.H., Farag, T.I., and  Mohamed, A.H. Apoptic and vascular changes in trichinella spiralis infected mice after parenteral artmether treatment. Journal of the Egyptian Society of Parasitology<\/em>, 2019; 49(1): 17-27.
     CrossRef <\/a><\/li>
  4. Wu, Z., Sofronic-Milosavljevic, L., Nagano, I., and Takahashi, Y. Trichinella spiralis<\/em>: nurse cell formation with emphasis on analogy to mus\u00adcle cell repair. Parasit Vectors<\/em> 2008; 1: 27.
    CrossRef <\/a><\/li>
  5. Ding, J., Liu, X., Bai, X., Wang, Y., Li, J., Wang, C., Li, S., Liu, M. and Wang, X., Trichinella spiralis: inflammation modulator. Journal of helminthology. 2020;94:e193.
     CrossRef <\/a><\/li>
  6. ElGhannam, M., Dar, Y., ElMehlawy, M.H., Mokhtar, F.A. and Bakr, L., Eugenol; Effective Anthelmintic Compound against Foodborne Parasite Trichinella Spiralis Muscle Larvae and Adult. Pathogens 2023;12(1):127.
     CrossRef <\/a><\/li>
  7. Saad, A.E., and Ghanem, H.B. Trichinella spiralis as a potential therapeutic agent: from a risky disease to a friend. Journal of the Egyptian Society of Parasit.<\/em> 2020; 50(1):119-26.
     CrossRef<\/a> <\/li>
  8. Abou Rayia, D., Othman, A., Harras, S., Helal, D., Dawood, L. and Soliman, S. A new take on therapy of muscle phase of Trichinella spiralis infection. Acta tropica<\/em>. 2022; 230: 106409.
     CrossRef <\/a><\/li>
  9. Yadav, A.K, and Temjenmongla, A. Efficacy of Lasia spinosa leaf extract in treating mice infected with T. spiralis. Parasitol. Res<\/em>., 2012; 110: 1-493.
    CrossRef <\/a><\/li>
  10. Gottstein, B., Pozio, E., and N\u00f6ckler, K. Epidemiology, diagnosis, treat\u00adment, and control of trichinellosis. Clin Microbiol Rev.<\/em> 2009; 22: 127-145.
    CrossRef <\/a><\/li>
  11. Caner, A., Doskaya, M., Degirmenci, A., et al<\/em>. Comparison of the effects of Artemisia vulgaris <\/em>and Artemisia absinthium <\/em>growing inwestern Anatolia against trichinellosis (Trichinella spiralis<\/em>) in rats. Exp. Parasitol<\/em>. 2008; 119:173-9.
     CrossRef <\/a><\/li>
  12. Mutar, T.F., Tousson, E., Hafez, E., Abo Gazia, M. and Salem, S.B. Ameliorative effects of vitamin B17 on the kidney against Ehrlich ascites carcinoma induced renal toxicity in mice. Environmental Toxicol.<\/em> 2020; 35(4): 528-537.
     CrossRef <\/a><\/li>
  13. Essawy, A.E., El-Sayed, S.A., Tousson, E., Abd El-gawad, H.S., Alhasani, R.H. and Abd Elkader, H.T.A.E.,  Anti-kindling effect of Ginkgo biloba leaf extract and L-carnitine in the pentylenetetrazol model of epilepsy. Environmental Science and Pollution Res.<\/em> 2022; 29: 48573\u201348587.
    CrossRef <\/a><\/li>
  14. Alankooshi A.A., Hasan A. F., Tousson E., El-Atrsh A, Mohamed T.M. Impact of coriander seeds extract against thyroidectomy induced testicular damage and DNA replication in male rats. OnLine Journal of Biological Sciences<\/em> 2023; 23 (2): 193.201. DOI: 10.3844\/ojbsci.2023.193.201
    CrossRef <\/a><\/li>
  15. Momin, A.H., Acharya, S.S., and Gajjar, A.V. Coriandrum sativum-review of advances in phytopharmacology. Int. J. Pharm. Sci<\/em>. 2012; 3: 1233. <\/li>
  16. Moustafa, A.H.A., Ali, E.M.M., Moselhey, S.S., Tousson, E. and El-Said, K.S., Effect of coriander on thioacetamide-induced hepatotoxicity in rats. Toxicology and industrial health<\/em>, 2014; 30(7): 621-629.
     CrossRef <\/a><\/li>
  17. Dunn, IJ, and Wright, KA. Cell injury caused by Trichinella spiralis <\/em>in the mucosal epithelium in mice. J. Parasitol<\/em>. 1985; 71:757-66.
     CrossRef <\/a><\/li>
  18. Bocktor, N.Z., EL-Saied, M.O., and Imam. N.F. Effect of lactobacillus acidophilus on trichinella spiralis muscle larvae in experimentally infected mice compared to its effect when combined with albendazole and\/or nitazoxanide. Journal of the Egyptian Society of Parasitol.<\/em> 2022; 52(1):107-16.
     CrossRef <\/a><\/li>
  19. Reitman, S. and Frankel, S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. American journal of clinical pathology<\/em>, 1957; 28(1):56-63.
     CrossRef <\/a><\/li>
  20. Belfield, A., and Goldberg, D.M. Revised assay for serum phenyl phosphatase activity using 4-amino-antipyrine. Enzyme<\/em>. 1971; 12(5):561-73.
     CrossRef <\/a><\/li>
  21. Simonian, M.H. Spectrophotometric determination of protein concentration. Current Protocols in Cell Biology<\/em> 2002; 15(1):A-3B.
     CrossRef <\/a><\/li>
  22. bd Eldaim, M.A., Tousson, E., Soliman, M.M., El Sayed, I.E.T., Abdel Aleem, A.A.H. and Elsharkawy, H.N. Grape seed extract ameliorated Ehrlich solid tumor-induced hepatic tissue and DNA damage with reduction of PCNA and P53 protein expression in mice. Environmental Science and Pollution Research<\/em> 2021; 28(32):44226-38.
    CrossRef <\/a><\/li>
  23. Patton, C., and Crouch, S. Determination of serum urea. Anal Chem<\/em> 1977; 49:464\u2013469.
     CrossRef <\/a><\/li>
  24. Ribicich, M., Gamble, H.R., Rosa, A., Sommerfelt, I., Marquez, A., Mira, G., Cardillo, N., Cattaneo, M.L., Falzoni, E. and Franco, A., Clinical, haematological, biochemical and economic impacts of Trichinella spiralis infection in pigs. Veterinary parasitol.<\/em> 2007; 147(3-4):265-270.
     CrossRef <\/a><\/li>
  25. Abu El Ezz, N.M. Effects of Nigella sativa <\/em>and Allium cepa <\/em>oils on Trichinella spiralis <\/em>inexperimentally infected rats. J. Egypt. Soc. Parasitol<\/em>.2005; 35 (2):511-23.<\/li>
  26. Soliman, G.A., Taher, E.S., and Mahmoud, M.A., Therapeutic effects of Dormectin, ivermectinand levamisole against different stages ofTrichinella spiralis <\/em>in rats. Turk. Parasitol. Deg<\/em>. 2011; 35:86-91.
     CrossRef <\/a> <\/li>
  27. Laribi, B., Kouki, K., M\u2019Hamdi, M., and Bettaieb, T. Coriander (Coriandrum sativum L.) and its bioactive constituents. Fitoterapia<\/em> 2015; 103: 9\u201326.
    CrossRef<\/a> <\/li>
  28. Al-Snafi, A.E. Antiparasitic, antiprotozoal, molluscicidal and insecticidal activity of medicinal plants (part 2)\u2013plant based review. Sch. Acad. J. Pharm<\/em>. 2016; 5: 194\u2013207.
    CrossRef <\/a><\/li>
  29. Sugane, K., Kusama, Y. Takamoto, M., Tominaga, A.,Takatsu, K.: Eosinophilia, IL-5 level and recovery of larvae in IL-5 transgenic mice infected with Toxocara canis. J. Helminthol<\/em>. 1996; 2: 153-158.
     CrossRef <\/a><\/li>
  30. Oto, S., Komiyama, A., Johkura, K., Hasegawa, O., Kondo, K.: Eosinophilic meningo-encephalo-myelitis due to Toxocara canis. Rinsho Shinkeigaku<\/em>. 1994; 11: 1148-1152.<\/li>
  31. Takamoto, M., Wang, Z.X., Watanate, N., Matsuzawa, A., Nariuchi, H., Sugane., K.: Eosinophilia, IgE production, and cytokine by lung T cells in surface CD4-deficient mutant mice infected with Toxocara canis. Immunology<\/em> 1998; 95: 97-104.
    CrossRef <\/a><\/li>
  32. Ovington, K.S., Behm, C.A.: The enigmatic eosinophil investigation of the biological role of eosinophils in parasitic helminth infection. Mem. Inst. Oswaldo Cruz<\/em>. 1997; 2: 93-104.
     CrossRef <\/a><\/li>
  33. Gamble, H.R., Wisnewski, N., and Wasson, D.L. Diagnosis of trichinello\u00adsis in swine by enzyme immunoassay, using a synthetic glycan antigen. Am J Vet Res R<\/em> 1997; 58: 1417-1421.
     CrossRef <\/a><\/li>
  34. Nada, S., Mohammad, S.M., Moad, H.S., El-shafey, M.A., Al-ghandour, A.M., and Ibrahim, N. Therapeutic effect of Nigella sativa and ivermectin versus albendazole on experimental trichinellosis in mice. Journal of the Egyptian Society of Parasitol.<\/em> 2018; 48(1): 85-92.
     CrossRef <\/a><\/li>
  35. Saggu, S., Sakeran, M.I., Zidan, N., Tousson, E., Mohan, A. and Rehman, H. Ameliorating effect of chicory (Chichorium intybus L.) fruit extract against 4-tertoctylphenol induced liver injury and oxidative stress in male rats. Food and Chem. Toxicol<\/em>. 2014; 72(10): 138-1.
     CrossRef <\/a><\/li>
  36. Adeyemi, O., Ajayi, J.O., Olajuyin, A.M., Oloyede, O.B., Oladiji, A.T., Oluba, O.M., Ololade, I.A. and Adebayo, E.A.  Toxicological evaluation of the effect of water contaminated with lead, phenol and benzene on liver, kidney and colon of Albino rats. Food and Chemical Toxicol<\/em>. 2009; 47(2): 885\u2013887.
     CrossRef <\/a><\/li>
  37. Mikhail, E.The occurrence of T. spiralis <\/em>larvae in tissues other than skeletal muscles. J. Egypt. Soc. Parasitol<\/em>. 1979; 9(1):269-72.<\/li>
  38. Basyoni, M.M., and El-Sabah, A.A. Therapeutic potential of myrrh and ivermectin against experimental Trichinella spiralis infection in mice. Korean J. Parasitol<\/em>., 2013; 51(3): 297-304.
     CrossRef <\/a><\/li><\/ol>\n","protected":false},"excerpt":{"rendered":"

    Introduction Trichinellosis is a parasitic zoonosis that is spread through […]<\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[113],"tags":[],"class_list":["post-56131","post","type-post","status-publish","format-standard","hentry","category-vol17no1"],"_links":{"self":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/56131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/comments?post=56131"}],"version-history":[{"count":5,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/56131\/revisions"}],"predecessor-version":[{"id":57444,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/posts\/56131\/revisions\/57444"}],"wp:attachment":[{"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/media?parent=56131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/categories?post=56131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biomedpharmajournal.org\/staging\/wp-json\/wp\/v2\/tags?post=56131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}